ViroGates announces its Interim Report for Q3, 2020 - Increasing revenue and two new clinical routine customers


BIRKERØD, DENMARK - ViroGates A/S, a medical technology company developing blood tests for better triaging in hospitals to improve patient care and reduce healthcare costs, today announces its Interim Report for the period 1 July 2020 – 30 September 2020, as approved by the company’s Board of Directors.

Läs hela meddelandet på ViroGates hemsida.

Läs mer..

Västra Hamnen Corporate Finance AB | Jungmansgatan 12 | 211 11 Malmö | 040-200 250 |